Suggestions from Geroscience for the Genetics of Age-Related Diseases.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Strong impact of natural-selection-free heterogeneity in genetics of age-related phenotypes.Aging · 2018
   Pooled it
2. Integrative effects of saffron and physical activity on endurance performance, quality of life, cognitive, emotional, and metabolic outcomes in age-related and neurodegenerative diseases.Frontiers in nutrition · 2025
   Review
3. Healthy ageing in the time of COVID-19: A wake-up call for action.Maturitas · 2021
   Article
4. Quantitative and Qualitative Role of Antagonistic Heterogeneity in Genetics of Blood Lipids.The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
   Article
5. Wandering along the epigenetic timeline.Clinical epigenetics · 2020
   Review
6. Polygenic risk score for disability and insights into disability-related molecular mechanisms.GeroScience · 2019
   Article
7. Pleiotropic Meta-Analysis of Age-Related Phenotypes Addressing Evolutionary Uncertainty in Their Molecular Mechanisms.Frontiers in genetics · 2019
   Article
8. Impact of demography and population dynamics on the genetic architecture of human longevity.Aging · 2018
   Article
9. The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.Frontiers in medicine · 2018
   Review
10. The epigenetic landscape of age-related diseases: the geroscience perspective.Biogerontology · 2017
    Review
11. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?Frontiers in immunology · 2017
    Review

Corrections and comments

• Comment on
  Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality.2016

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as